Oestrogen Receptor Function at Classical and Alternative Response Elements
The DOI matches its Crossref record.
Abstract
The oestrogen receptor (ER), bound to classical response elements (EREs) in the promoter of target genes, activates transcription by recruiting coactivator proteins. We will describe structural studies that show that oestrogens allow the formation of a hydrophobic cleft on the surface of the ER that serves as a docking site for coactivators. Anti-oestrogens displace part of the receptor, which then occludes the site, blocking coactivator access. In addition to activating at classical EREs, the ER activates transcription at alternative elements such as AP-1 sites. These bind the Jun/Fos proteins but not ER. Interestingly both oestrogen and tamoxifen activate transcription at AP-1 sites. We propose a mechanism whereby oestrogen and anti-oestrogen allow ER to activate transcription from alternative response elements. ER binds to the coactivators, CBP and GRIP1, that have been recruited by Jun/Fos and through this contact 'triggers' these coactivators into full activity. In this circumstance the ER is part of the coactivator complex for Jun/Fos.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Integration of the extranuclear and nuclear actions of estrogen
Levin, E. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0390 · Cited by 708
Extranuclear Steroid Receptors: Nature and Actions
Hammes, S. R., & Levin, E. R. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0022 · Cited by 475
Wickramasinghe, N. S., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., & Klinge, C. M. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp117 · Cited by 391
Anatomy of the estrogen response element
Gruber, C. J., Gruber, D. M., Gruber, I. M. L., Wieser, F., & Huber, J. C. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.01.008 · Cited by 319
Estrogen Receptor Target Gene: An Evolving Concept
Carroll, J. S., & Brown, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0334 · Cited by 284
Vivacqua, A., Bonofiglio, D., Albanito, L., Madeo, A., Rago, V., Carpino, A., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026344 · Cited by 280
RetractedPregnancy and the risk of breast cancer
Britt, K., Ashworth, A., & Smalley, M. (2007) · Endocrine Related Cancer · doi:10.1677/erc-07-0137 · Cited by 254
Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis
Shang, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1879 · Cited by 246
Wang, C., Mayer, J. A., Mazumdar, A., Fertuck, K., Kim, H., Brown, M., & Brown, P. H. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1037 · Cited by 194
“Some previous studies show that ER may act as a coactivator to enhance the activity of AP-1 to regulate the expression of target genes, such as matrix metalloproteinase-1, fibronection-1, and cyclin D1 (6, 35–37).”
BackgroundEstrogen regulation of placental angiogenesis and fetal ovarian development during primate pregnancy
Albrecht, E. D., & Pepe, G. J. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082758ea · Cited by 191
“…et al., 2000), estrogen gene regulation is a multifactorial process controlled via interaction between estrogen receptors and transcription factors (Kushner et al., 2000; Bjornstrom and Sjoberg, 2005), notably hypoxia-inducible factor-1, which is recruited along with estrogen receptor α to the…”
Background
Metadata
- Authors
- Kushner, P. J., Agard, D., Feng, W., Lopez, G., Schiau, A., Uht, R., Webb, P., & Greene, G.
- Venue
- Novartis Foundation Symposia
- Publisher
- Wiley
- Published
- 2000-06-27
- Volume
- 230
- Pages
- 20-32
- ISSN
- 1528-2511 (ISSN-L)
- 1935-4657
- OpenAlex
- W1606602062
- Cited by
- 76
- References
- 0
- Type
- other
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.